Results from the NRG Oncology NRG-RTOG 0232 clinical trial adding external beam radiotherapy (EBRT) to brachytherapy (BT) in men with intermediate-risk prostate cancer indicate that there was no improvement in freedom from progression (FFP) rates for patients.
New multi-polygenic scores boost coronary heart disease prediction accuracy
Two multi-polygenic scores (muti-PGs) to predict coronary heart disease (CHD).
September 28, 2023